MSS/ MMRp
Who we are
A Study to Evaluate MEDI5752 in Subjects With Advanced Solid Tumors
The Efficacy of JS001 Combined With Chemotherapy in Patients With Locally Advanced Colon Cancer
A Study of TSR-022 in Participants With Advanced Solid Tumors (AMBER)
Avelumab, Utomilumab, Anti-OX40 Antibody PF-04518600, and Radiation Therapy in Treating Patients With Advanced Malignancies
Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic Cancer
A Study of BMS-986253 in Combination With Nivolumab or Nivolumab Plus Ipilimumab in Advanced Cancers
A Trial of BI 765063 Monotherapy and in Combination With BI 754091 in Patients With Advanced Solid Tumours
Study of Pembrolizumab, Binimetinib, and Bevacizumab in Patients With Refractory Colorectal Cancer
Neoadjuvant Safety of Sintilimab + XELOX + Bevacizumab in pMMR/MSS CRLM Patients
INNATE: Immunotherapy During Neoadjuvant Therapy for Rectal Cancer
